Alnylam announced the FDA approval of its supplemental new drug application for vutrisiran, an RNA interfering small molecule ...
The Food and Drug Administration (FDA) has approved Amvuttra ® (vutrisiran) for the treatment of the cardiomyopathy of ...
A new study conducted by researchers from the Washington University School of Medicine identified an experimental drug that ...
An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...
Amyloidosis Awareness Month is observed annually in March. Every year, Denham Springs nurse, Megan Alford, highlights the ...
ScienceAlert on MSN4d
Anti-Amyloid Drug May Delay Alzheimer's Symptoms in Those at Risk, Clinical Trial FindsA method for slowing disease progress in Alzheimer's patients may also delay onset in people predisposed to the disease who ...
Background Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) often experience worsening cardiac disease (WCD) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback